TGA Approval

TRILEPTAL oxcarbazepine 60mg/mL oral suspension bottle (81195)

ARTG ID

81195

ARTG Name

TRILEPTAL oxcarbazepine 60mg/mL oral suspension bottle

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

December 17, 2001

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/305111795e64471f027f9c1b3d669ddf.pdf

https://medical-cdn.nocode.com/drug_tga/49534bc9e032e4ae97d0b4ceef253387.pdf

Ingredient Name

oxcarbazepine

Empowering clinical research with data-driven insights and AI-powered tools.

TRILEPTAL oxcarbazepine 60mg/mL oral suspension bottle (81195) - TGA 批准文号 | MedPath